New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S2652

Introduced
2/12/24  
Introduced
1/13/26  
Refer
2/12/24  
Refer
1/13/26  
Report Pass
3/7/24  
Engrossed
5/20/24  
Refer
5/20/24  
Report Pass
6/13/24  
Enrolled
9/26/24  
Chaptered
11/18/24  

Caption

Revises statutory terms pertaining to sexual exploitation or abuse of children.

Impact

The legislation is anticipated to significantly impact state laws by formalizing a framework that allows community hubs and educational institutions to manage and distribute opioid antidotes. The Department of Health is tasked with creating a program that will monitor and report on opioid overdose trends statewide. Annual reports will include critical data on overdose rates, emergency room visits related to overdoses, and the effectiveness of response efforts. These measures are expected to streamline information sharing and improve resource allocation to areas hardest hit by the opioid crisis.

Summary

Senate Bill S2652 seeks to enhance and expand the distribution and availability of opioid antidotes, specifically naloxone, within New Jersey. The bill amends existing statutes related to the Overdose Prevention Act by allowing not only health care professionals but also community hubs, including schools, to acquire and administer opioid antidotes. By enabling these entities to hold opioid antidotes on-site, the bill aims to combat the rising rates of opioid overdoses and deaths throughout the state. This initiative reflects a proactive approach to improve public health responses to drug overdoses, especially in populated and vulnerable areas.

Sentiment

Responses to the bill have been generally positive among public health advocates and lawmakers focusing on drug crisis interventions. Supporters argue that S2652 is a necessary step toward enhancing public health safety and lowering overdose mortality rates. Critics, however, may express concerns over the potential misuse of opioid antidotes or the implications of training non-medical personnel to administer such treatments. Nonetheless, the sentiment leans toward recognizing the urgency of tackling the opioid epidemic through accessible solutions, which S2652 strives to provide.

Contention

Debate surrounding S2652 includes discussions about the scope of authority granted to non-traditional entities like community hubs and schools in administering medical interventions. Concerns about liability, proper training of personnel, and the potential risks associated with broader availability of opioids are notable points of contention. The bill enhances liability protections for individuals who prescribe or administer antidotes in good faith, addressing fears around legal repercussions. The challenge remains to balance accessibility with safety measures while ensuring that such programs do not inadvertently lead to further prescription drug misuse.

Companion Bills

NJ A3539

Same As Revises statutory terms pertaining to sexual exploitation or abuse of children.

Previously Filed As

NJ S2625

Creates separate crime for items depicting sexual exploitation or abuse of children; concerns computer generated or manipulated sexually explicit images.

NJ A2312

Creates separate crime for items depicting sexual exploitation or abuse of children; concerns computer generated or manipulated sexually explicit images.

NJ S2652

Expands entities that may acquire opioid antidotes; creates program within DOH and formalizes reporting requirements.

NJ S4094

Revises statutory law to change title of "physician assistant" to "physician associate."

NJ A4958

Revises statutory law to change title of "physician assistant" to "physician associate."

NJ HB266

Penalty For Sexual Exploitation Of Children

NJ HB0171

Sexual exploitation of children-amendments.

NJ A2783

Revises law concerning sexually oriented businesses.

NJ S1410

Amends statutory law to change title of "physician assistant" to "physician associate."

NJ A816

Increases fines for failing to report suspected abuse or exploitation of institutionalized elderly person.

Similar Bills

No similar bills found.